Outsourcing STREAM
-
IQVIA Biotech: Clinical Development
3/4/2021
Are you preparing to initiate your clinical trial? Trying to get your next milestone quickly? Determining whether to outsource? We can help you answer the questions that keep you up at night.
-
A Different Kind Of CRO
1/30/2023
Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.
-
Why Functional Outsourcing Is Important To Clinical Development
8/1/2025
Craig McIlloney, Senior Vice President of Catalyst Flex, discusses why functional outsourcing is important in today's clinical development environment, how Catalyst Flex supports this, and is scalable to flex to your changing needs.
-
Proactive Drug Development: Explained
1/30/2023
Watch this short video to learn about Proactive Drug Development with Altasciences.
-
How To Boost Disclosure Efficiencies With Outsourcing
11/1/2018
In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.
-
Imagine⦠Easier, Proactive Drug Development
2/14/2023
Imagine partnering with a single CRO/CDMO for your early phase drug development. With Altasciences, you don’t have to imagine—learn how they’re able to deliver for your project.
-
The Heart Of The Matter: Early Vs. Late QT Prolongation Testing
2/8/2023
Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.
-
Early Phase Clinical Development Solutions
1/30/2023
Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives.
-
Successful Manufacturing Of Clinical Trial Supply
8/27/2024
Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.